REPLIMUNE GROUP, INC.
Ownership & governance
Executives 5Directors 10Avg age 59Avg tenure 4.3y
SP
Sushil Patel
Chief Executive Officer
Age 55Since 2024-03-31Profile →
+14
Executives5
SP
Sushil Patel→
Chief Executive Officer
Age 55Since 2024-03-31
EH
Emily Hill→
Director of Finance/CFO
Age 46Since 2023-09-18
KX
Konstantinos Xynos→
Chief Tech/Sci/R&D Officer
Age 60Since 2022-11-30
NA
Nina Aragam
Corporate Officer/Principal
—Since 2022-12-31
SG
Shawn Glidden
General Counsel
—Since 2020-12-31
Board of directors10
PA
Philip Astley-Sparke→
Chairman
Age 54Since 2024-03-31
KD
Kapil Dhingra→
Director/Board Member
Age 66Since 2017-06-30
DW
Dieter Weinand→
Chairman
Age 65Since 2020-03-31
JS
Joseph Slattery→
Director/Board Member
Age 61Since 2017-09-30
PP
Paolo Pucci→
Director/Board Member
Age 64Since 2020-03-31
SP
Sushil Patel→
Director/Board Member
Age 55Since 2024-03-31
CO
Christy Oliger→
Director/Board Member
Age 56Since 2021-11-30
VP
Veleka Peeples-Dyer→
Director/Board Member
Age 54Since 2023-05-31
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Baker Bros. Advisors LP | 14.15 % | 11,045,336 |
| Baker Bros. Advisors LP | 14.15 % | 11,045,336 |
| T. Rowe Price International Ltd. | 10.4 % | 8,121,433 |
| RTW Investments LP | 9.425 % | 7,356,916 |
| Ridgeback Capital Management LLC | 8.01 % | 6,252,651 |
Catalog · 2026-07-09
Proxy officers21
| Name | Role | Since | Shares |
|---|---|---|---|
| Dieter Weinand | Chairman | 2020-03-31 | - |
| Philip Astley-Sparke | Chairman | 2024-03-31 | - |
| Christy Oliger | Director or executive officer | 2021-01-01 | 138,700 |
| Christy Oliger | Director/Board Member | 2021-11-30 | - |
| Dieter Weinand | Director or executive officer | 2018-06-01 | 216,550 |
| Emily Hill | Director or executive officer | — | 239,784 |
| Joseph Slattery | Director or executive officer | 2017-01-01 | 204,756 |
| Joseph Slattery | Director/Board Member | 2017-09-30 | - |
Proxy · as of 2026-09-15
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 19.5Range 14–24Analysts 6
14Mean 19.524
- Strong buy 2
- Buy 5
- Sell 1
Broker actions40 of 102
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Overweight | 21 | 2026-08-26 |
| JP Morgan | Maintained | Overweight | 20 | 2026-08-07 |
| Wedbush | Upgrade | Outperform | 19 | 2026-08-07 |
| Leerink Partners | Upgrade | Outperform | 17 | 2026-08-04 |
| Wedbush | Maintained | Neutral | 12 | 2026-07-31 |
| Cantor Fitzgerald | Upgrade | Overweight | — | 2026-07-31 |
| Wedbush | Maintained | Neutral | 9 | 2026-06-30 |
| JP Morgan | Upgrade | Overweight | 17 | 2026-06-26 |
| Wedbush | Maintained | Neutral | 6 | 2026-06-01 |
| JP Morgan | Upgrade | Neutral | 8 | 2026-05-29 |
| Cantor Fitzgerald | Downgrade | Neutral | — | 2026-04-13 |
| Leerink Partners | Downgrade | Market Perform | 2 | 2026-04-13 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.